registry_id stringlengths 17 17 | year int64 2.01k 2.02k | age int64 0 95 | age_group stringclasses 8
values | sex stringclasses 2
values | cancer_type stringclasses 22
values | morphology stringclasses 8
values | grade stringclasses 5
values | basis_of_diagnosis stringclasses 5
values | behavior stringclasses 3
values | residence stringclasses 3
values | treatment_status stringclasses 8
values | vital_status stringclasses 3
values | survival_months float64 0 60 | scenario stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KE-NRB-2010-00001 | 2,010 | 45 | 45-54 | Male | Oesophagus | Lymphoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 34.1 | high_burden |
KE-NRB-2018-00002 | 2,018 | 24 | 15-24 | Female | Other | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 25.8 | high_burden |
KE-NRB-2013-00003 | 2,013 | 42 | 35-44 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Urban | Surgery only | Lost to follow-up | 60 | high_burden |
KE-NRB-2015-00004 | 2,015 | 71 | 65-74 | Male | Colorectum | Sarcoma | Unknown | Microscopy (histology/cytology) | Benign/uncertain | Peri-urban | null | Dead | 19 | high_burden |
KE-NRB-2012-00005 | 2,012 | 54 | 45-54 | Female | Thyroid | Squamous cell carcinoma | Poorly differentiated (Grade III) | Clinical only | Malignant | Urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2014-00006 | 2,014 | 81 | 75+ | Female | Breast | Sarcoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 38.3 | high_burden |
KE-NRB-2012-00007 | 2,012 | 17 | 15-24 | Male | Bladder | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 0.8 | high_burden |
KE-NRB-2017-00008 | 2,017 | 52 | 45-54 | Female | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 54.2 | high_burden |
KE-NRB-2016-00009 | 2,016 | 36 | 35-44 | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 3.6 | high_burden |
KE-NRB-2015-00010 | 2,015 | 52 | 45-54 | Female | Corpus uteri | Lymphoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 11.1 | high_burden |
KE-NRB-2012-00011 | 2,012 | 67 | 65-74 | Female | Other | Leukemia | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 38.1 | high_burden |
KE-NRB-2016-00012 | 2,016 | 43 | 35-44 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Death certificate only | Malignant | Peri-urban | Surgery only | Dead | 34.1 | high_burden |
KE-NRB-2013-00013 | 2,013 | 78 | 75+ | Female | Breast | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Dead | 10.4 | high_burden |
KE-NRB-2009-00014 | 2,009 | 48 | 45-54 | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2017-00015 | 2,017 | 61 | 55-64 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Palliative care only | Alive | 22.4 | high_burden |
KE-NRB-2016-00016 | 2,016 | 67 | 65-74 | Female | Cervix uteri | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Dead | 24.1 | high_burden |
KE-NRB-2013-00017 | 2,013 | 47 | 45-54 | Female | Other | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 57 | high_burden |
KE-NRB-2017-00018 | 2,017 | 56 | 55-64 | Male | Kaposi sarcoma | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 6.6 | high_burden |
KE-NRB-2017-00019 | 2,017 | 44 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 16 | high_burden |
KE-NRB-2010-00020 | 2,010 | 41 | 35-44 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 13.8 | high_burden |
KE-NRB-2015-00021 | 2,015 | 29 | 25-34 | Female | Cervix uteri | Adenocarcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Peri-urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2015-00022 | 2,015 | 35 | 35-44 | Female | Breast | Non-keratinizing carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2013-00023 | 2,013 | 50 | 45-54 | Female | Thyroid | Adenocarcinoma | Undifferentiated (Grade IV) | Other | Malignant | Urban | Surgery + Radiotherapy | Dead | 9.2 | high_burden |
KE-NRB-2015-00024 | 2,015 | 57 | 55-64 | Male | Oesophagus | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 3.6 | high_burden |
KE-NRB-2016-00025 | 2,016 | 46 | 45-54 | Male | Oesophagus | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 15.8 | high_burden |
KE-NRB-2012-00026 | 2,012 | 56 | 55-64 | Female | Ovary | Other specified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Rural | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2012-00027 | 2,012 | 74 | 65-74 | Female | Breast | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2014-00028 | 2,014 | 35 | 35-44 | Male | Bladder | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2009-00029 | 2,009 | 39 | 35-44 | Female | Other | Other specified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Benign/uncertain | Urban | null | Dead | 23.3 | high_burden |
KE-NRB-2014-00030 | 2,014 | 39 | 35-44 | Female | Breast | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 38 | high_burden |
KE-NRB-2014-00031 | 2,014 | 35 | 35-44 | Female | Other | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery + Chemotherapy | Alive | 14.5 | high_burden |
KE-NRB-2018-00032 | 2,018 | 90 | 75+ | Male | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Malignant | Urban | Chemotherapy only | Dead | 6 | high_burden |
KE-NRB-2014-00033 | 2,014 | 52 | 45-54 | Female | Ovary | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Rural | Surgery only | Lost to follow-up | 32.4 | high_burden |
KE-NRB-2012-00034 | 2,012 | 74 | 65-74 | Female | Other | Sarcoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery + Chemotherapy | Alive | 35.1 | high_burden |
KE-NRB-2015-00035 | 2,015 | 29 | 25-34 | Male | Pancreas | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 7 | high_burden |
KE-NRB-2016-00036 | 2,016 | 54 | 45-54 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 25.3 | high_burden |
KE-NRB-2011-00037 | 2,011 | 73 | 65-74 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 17.6 | high_burden |
KE-NRB-2017-00038 | 2,017 | 61 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Poorly differentiated (Grade III) | Clinical only | Malignant | Urban | Surgery only | Alive | 19 | high_burden |
KE-NRB-2014-00039 | 2,014 | 67 | 65-74 | Male | Colorectum | Lymphoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Lost to follow-up | 47.9 | high_burden |
KE-NRB-2009-00040 | 2,009 | 2 | 0-14 | Female | Breast | Lymphoma | Unknown | Clinical only | Malignant | Rural | Surgery + Radiotherapy | Alive | 1.1 | high_burden |
KE-NRB-2011-00041 | 2,011 | 67 | 65-74 | Male | Other | Unspecified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 46.8 | high_burden |
KE-NRB-2013-00042 | 2,013 | 23 | 15-24 | Male | Other | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Palliative care only | Alive | 60 | high_burden |
KE-NRB-2018-00043 | 2,018 | 56 | 55-64 | Male | Prostate | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 40 | high_burden |
KE-NRB-2017-00044 | 2,017 | 39 | 35-44 | Male | Prostate | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 8.2 | high_burden |
KE-NRB-2018-00045 | 2,018 | 46 | 45-54 | Female | Cervix uteri | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 4 | high_burden |
KE-NRB-2018-00046 | 2,018 | 32 | 25-34 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 38.1 | high_burden |
KE-NRB-2016-00047 | 2,016 | 49 | 45-54 | Female | Ovary | Other specified | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 3.9 | high_burden |
KE-NRB-2009-00048 | 2,009 | 19 | 15-24 | Male | Prostate | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 11 | high_burden |
KE-NRB-2013-00049 | 2,013 | 63 | 55-64 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 23.3 | high_burden |
KE-NRB-2018-00050 | 2,018 | 35 | 35-44 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Radiotherapy only | Alive | 12.4 | high_burden |
KE-NRB-2014-00051 | 2,014 | 66 | 65-74 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 1 | high_burden |
KE-NRB-2014-00052 | 2,014 | 44 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 11.3 | high_burden |
KE-NRB-2016-00053 | 2,016 | 78 | 75+ | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 1.7 | high_burden |
KE-NRB-2009-00054 | 2,009 | 60 | 55-64 | Male | Stomach | Non-keratinizing carcinoma | Unknown | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 43.1 | high_burden |
KE-NRB-2018-00055 | 2,018 | 39 | 35-44 | Female | Thyroid | Non-keratinizing carcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2010-00056 | 2,010 | 63 | 55-64 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 21.9 | high_burden |
KE-NRB-2009-00057 | 2,009 | 36 | 35-44 | Female | Cervix uteri | Other specified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2018-00058 | 2,018 | 36 | 35-44 | Female | Breast | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 9.2 | high_burden |
KE-NRB-2013-00059 | 2,013 | 33 | 25-34 | Male | Other | Leukemia | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery only | Lost to follow-up | 5.7 | high_burden |
KE-NRB-2013-00060 | 2,013 | 50 | 45-54 | Male | Lung | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Benign/uncertain | Urban | null | Alive | 60 | high_burden |
KE-NRB-2018-00061 | 2,018 | 52 | 45-54 | Female | Breast | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2018-00062 | 2,018 | 28 | 25-34 | Female | Breast | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Lost to follow-up | 24.9 | high_burden |
KE-NRB-2018-00063 | 2,018 | 64 | 55-64 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 16.4 | high_burden |
KE-NRB-2015-00064 | 2,015 | 52 | 45-54 | Male | Pancreas | Adenocarcinoma | Undifferentiated (Grade IV) | Imaging + clinical | Malignant | Urban | Chemo + Radiotherapy | Alive | 16.5 | high_burden |
KE-NRB-2013-00065 | 2,013 | 18 | 15-24 | Female | Cervix uteri | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 40 | high_burden |
KE-NRB-2016-00066 | 2,016 | 58 | 55-64 | Female | Cervix uteri | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 24.5 | high_burden |
KE-NRB-2015-00067 | 2,015 | 64 | 55-64 | Female | Breast | Other specified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | In situ | Urban | null | Alive | 58.1 | high_burden |
KE-NRB-2017-00068 | 2,017 | 34 | 25-34 | Female | Thyroid | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Radiotherapy only | Dead | 27.4 | high_burden |
KE-NRB-2017-00069 | 2,017 | 92 | 75+ | Male | Prostate | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Radiotherapy only | Lost to follow-up | 60 | high_burden |
KE-NRB-2014-00070 | 2,014 | 78 | 75+ | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 7 | high_burden |
KE-NRB-2016-00071 | 2,016 | 20 | 15-24 | Male | Leukemia | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 5.1 | high_burden |
KE-NRB-2014-00072 | 2,014 | 81 | 75+ | Female | Ovary | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 36.5 | high_burden |
KE-NRB-2014-00073 | 2,014 | 77 | 75+ | Female | Cervix uteri | Leukemia | Unknown | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 58.4 | high_burden |
KE-NRB-2016-00074 | 2,016 | 60 | 55-64 | Female | Breast | Squamous cell carcinoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2012-00075 | 2,012 | 87 | 75+ | Female | Cervix uteri | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 27.3 | high_burden |
KE-NRB-2013-00076 | 2,013 | 56 | 55-64 | Female | Breast | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Dead | 1.8 | high_burden |
KE-NRB-2010-00077 | 2,010 | 52 | 45-54 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 22.3 | high_burden |
KE-NRB-2015-00078 | 2,015 | 45 | 45-54 | Female | Cervix uteri | Squamous cell carcinoma | Undifferentiated (Grade IV) | Death certificate only | Malignant | Urban | Surgery + Chemotherapy | Dead | 11.1 | high_burden |
KE-NRB-2012-00079 | 2,012 | 54 | 45-54 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery + Chemotherapy | Alive | 60 | high_burden |
KE-NRB-2013-00080 | 2,013 | 16 | 15-24 | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 10.6 | high_burden |
KE-NRB-2009-00081 | 2,009 | 64 | 55-64 | Male | Colorectum | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 23 | high_burden |
KE-NRB-2010-00082 | 2,010 | 61 | 55-64 | Female | Other | Non-keratinizing carcinoma | Well differentiated (Grade I) | Clinical only | Malignant | Rural | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2009-00083 | 2,009 | 55 | 55-64 | Male | Colorectum | Sarcoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery only | Dead | 15.9 | high_burden |
KE-NRB-2017-00084 | 2,017 | 43 | 35-44 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery + Chemotherapy | Alive | 36.5 | high_burden |
KE-NRB-2013-00085 | 2,013 | 86 | 75+ | Male | Colorectum | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Dead | 19.3 | high_burden |
KE-NRB-2015-00086 | 2,015 | 12 | 0-14 | Male | Colorectum | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 1.2 | high_burden |
KE-NRB-2016-00087 | 2,016 | 44 | 35-44 | Male | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Alive | 55.9 | high_burden |
KE-NRB-2016-00088 | 2,016 | 58 | 55-64 | Male | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery + Chemotherapy | Alive | 11.2 | high_burden |
KE-NRB-2017-00089 | 2,017 | 63 | 55-64 | Female | Corpus uteri | Lymphoma | Undifferentiated (Grade IV) | Imaging + clinical | Malignant | Urban | No treatment | Lost to follow-up | 60 | high_burden |
KE-NRB-2013-00090 | 2,013 | 36 | 35-44 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2012-00091 | 2,012 | 40 | 35-44 | Female | Other | Adenocarcinoma | Unknown | Other | Malignant | Urban | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2011-00092 | 2,011 | 31 | 25-34 | Female | Cervix uteri | Sarcoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 38.1 | high_burden |
KE-NRB-2018-00093 | 2,018 | 60 | 55-64 | Male | Prostate | Squamous cell carcinoma | Unknown | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Dead | 6.5 | high_burden |
KE-NRB-2014-00094 | 2,014 | 41 | 35-44 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 0.1 | high_burden |
KE-NRB-2010-00095 | 2,010 | 52 | 45-54 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2016-00096 | 2,016 | 26 | 25-34 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2015-00097 | 2,015 | 67 | 65-74 | Male | Leukemia | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2010-00098 | 2,010 | 74 | 65-74 | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Death certificate only | In situ | Peri-urban | null | Dead | 39.3 | high_burden |
KE-NRB-2015-00099 | 2,015 | 61 | 55-64 | Female | Other | Adenocarcinoma | Unknown | Clinical only | Malignant | Urban | Chemotherapy only | Alive | 25.5 | high_burden |
KE-NRB-2014-00100 | 2,014 | 63 | 55-64 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 60 | high_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.